Scientech Research’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Scientech Research's AXSM Position: Q2 2026 in Review
Scientech Research opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 820 shares worth $201K. The stake represents 0.16% of the portfolio and ranks #163 among its holdings. This is a return to the name: Scientech Research previously reported a position in AXSM as recently as Q4 2025.
Scientech Research first reported a position in AXSM in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.14M in Q1 2025. 509 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.
- Scientech Research held 820 shares of Axsome Therapeutics worth $201K as of Q2 2026.
- Axsome Therapeutics was a new Scientech Research position in Q2 2026.
- Axsome Therapeutics made up 0.16% of Scientech Research's portfolio in Q2 2026, its #163 holding.
- Scientech Research first reported a position in Axsome Therapeutics in Q1 2025 and has held it in 3 quarters since.
- Scientech Research's Axsome Therapeutics position peaked at $1.14M in Q1 2025.
- 509 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.